Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer
This study is ongoing, but not recruiting participants.
Study NCT01081951
Information provided by AstraZeneca
First Received on February 26, 2010.
Last Updated on July 19, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
